Cancer

The National Institutes of Health has announced a notice of special interest for funding studies investigating the risk of cannabis treatments for cancer patients.

South Carolina is sending a medical cannabis bill to the House floor for consideration.

The Kentucky Senate will not vote on the state’s House-approved medical cannabis legislation because, according to Senate Majority Leader Damon Thayer (R), there are “not enough votes” to pass the bill.

Kentucky’s GOP-controlled House of Representatives voted 59-64 to pass a bill giving patients with certain severe illnesses access to a state medical cannabis program.

Texas medical cannabis dispensary Goodblend is going on a bus tour to promote enrollment in the state’s limited cannabis program. The tour is currently slated for four cities over five dates.

Cannabis use among cancer patients is lower than that of the general public, with just 9% of cancer patients having used cannabis compared to 14% of people with no cancer history according to a new study.

The United Kingdom National Health Service and Brain Tumour Charity are partnering on research to determine whether cannabis-based medicine Sativex paired with chemotherapy medication temozolomide can treat glioblastoma.

A new study published last week in Gynecologic Oncology Reports found 71% of gynecologic cancer patients reported self-improvement while using medical cannabis.

The Texas House approved expansions to the state’s medical cannabis program that would raise the THC limit from 0.5% to 5% and legalize access for patients with chronic pain, PTSD, and cancer.

Australian researchers found a 14-25 percent reduction in chemotherapy side effects in patients who received cannabis capsules during a recent study.

Government-backed researchers in Thailand found in a series of test tube studies that cannabis extracts may inhibit cancer cell growth.

Harvard researchers recently identified a specific cannabis flavonoid that was able to kill tumor cells in 70 percent of mice with pancreatic cancer.

Medical cannabis patients in Minnesota have reported a “significant reduction” in the severity of their cancer symptoms.

The study hopes to correct a lack of double-blind, placebo-controlled studies regarding cannabis’ effects on cancer symptoms.